Overview
Da Vinci is a proprietary trading house that develops and operates its own trading strategies. Its teams—traders, software engineers, researchers, and founders—work closely together to create and deploy algorithmic and data-driven trading approaches, aiming to outperform traditional methods. The company emphasizes a nonhierarchical culture, flexible internal mobility, and personal growth, with ownership and collaboration at the core of daily work. Its Amsterdam base connects it to a long trading history, but the product itself is built around smart, team-driven trading ideas and execution rather than external services. The goal is to become the best proprietary trading firm in the world by continually improving how they work and grow as a team.
Work here?Claim your company
Simplify's Take
What believers are saying
- March 2026 revenue rose 23% to $2.77 billion, driven by 847,000 procedures.
- June 2026 procedures reached 889,000, up 15%, showing sustained utilization growth.
- April 2026 reimbursement expanded to seven additional da Vinci procedures, including inguinal hernia repair.
What critics are saying
- Intuitive faces da Vinci antitrust trial on instrument repairs, scheduled for September 14, 2027.
- Product-liability lawsuits allege da Vinci defects, training failures, injuries, and deaths across multiple courts.
- March 1, 2026 distribution acquisition in Europe concentrates execution risk across Italy, Spain, Portugal, Malta.
What makes Da Vinci unique
- da Vinci remains the category leader, with 20 million patients treated globally by January 2026.
- Intuitive controls premium robotic surgery workflows, instruments, and service through the da Vinci installed base.
- March 2026 FDA clearance extended force-feedback instrument lives on da Vinci 5, strengthening switching costs.
Help us improve and share your feedback! Did you find this helpful?